Clinical trial

IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in…

NCT00307645 · Assistance Publique - Hôpitaux de Paris, Other · Terminated

Key facts

NCT number NCT00307645
Title IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
Official title Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
Lead sponsor Assistance Publique - Hôpitaux de Paris, Other
Status Terminated
Phase Phase 3
Study type Interventional
Conditions ANCA Associated Systemic Vasculitis Including Wegener's, Granulomatosis and Microscopic Polyangiitis and, Renal Limited Vasculitis
Intervention type Drug
Interventions Cyclophosphamide, Mycophenolate mofetil, Azathioprine, Prednisone (and methylprednisolone)
Enrollment 160
Start date May 1, 2003
Completion Aug 1, 2009
First posted Mar 28, 2006
Last update posted Apr 10, 2006
Countries France, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies